Antibiotice (BSE:ATB) Pre-Tax Income : lei91.5 Mil (TTM As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Antibiotice Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Antibiotice's pretax income for the three months ended in Dec. 2023 was lei2.8 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was lei91.5 Mil. Antibiotice's pretax margin was 2.07%.

During the past 13 years, Antibiotice's highest Pretax Margin was 15.23%. The lowest was 8.27%. And the median was 10.10%.

Antibiotice Pre-Tax Income Historical Data

The historical data trend for Antibiotice's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Antibiotice Pre-Tax Income Chart

Antibiotice Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

35.18

28.33

30.30

65.31

91.52

Antibiotice Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial															32.78	25.76	46.82	16.11	2.84

Competitive Comparison of Antibiotice's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Antibiotice's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Antibiotice's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Antibiotice's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Antibiotice's Pre-Tax Income falls into.

Antibiotice Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Antibiotice's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	96.959	+	0	+	-4.146	+	0.004	+	-1.293
	=	91.5

Antibiotice's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-2.131	+	0	+	-0.965	+	0.002	+	5.931
	=	2.8

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was lei91.5 Mil.

Antibiotice (BSE:ATB) Pre-Tax Income Explanation

Antibiotice's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	2.837	/	137.349
	=	2.07%

During the past 13 years, Antibiotice's highest Pretax Margin was 15.23%. The lowest was 8.27%. And the median was 10.10%.

Antibiotice Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Antibiotice's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Antibiotice (BSE:ATB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Antibiotice SA (BSE:ATB) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Valea Lupului Street, Iasi, ROU, 707410

Website

http://www.antibiotice.ro

Antibiotice Ord is a Romania based company engaged in manufacturing generic medicines. It primarily develops and produces generic medicines for human use, veterinary medicines and active substance Nystatin. The group's generic medicines are primarily targeted at patients with infections, dermatological, cardiovascular, digestive tract diseases or diseases of the musculoskeletal system. It manufactures firm powders for solutions for injection and suspensions for injection (penicillins), capsules, tablets, suppositories and topical preparations (ointments, gels, creams).

Antibiotice (BSE:ATB) Headlines

No Headlines